Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
- Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)Recruiting
Sponsor: Amgen
Extensive Stage Small Cell Lung Cancer
United States, Australia, Belgium, China, Germany +5 more
Sponsor: Bristol-Myers Squibb
Cardiomyopathy
Japan
Sponsor: Merck Sharp & Dohme LLC
Esophageal Squamous Cell Carcinoma
United States, Brazil, Chile, China, Germany +9 more
- A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic CardiomyopathyActive Not Recruiting
Sponsor: Bayer
Obstructive Hypertrophic Cardiomyopathy
Japan
Sponsor: China-Japan Friendship Hospital
ESRD (End-Stage Renal Disease) · Maintenance Hemodialysis
China
Sponsor: Amgen
Major Cardiovascular Event · Established Atherosclerotic Cardiovascular Disease
China
- Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and ChildrenCompleted
Sponsor: Guerbet
Lesion in Body Region · CNS Lesion
Japan
- A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)Active Not Recruiting
Sponsor: Acerta Pharma BV
Diffuse Large B-Cell Lymphoma
United States, Australia, Austria, Belgium, Brazil +18 more
- First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsActive Not Recruiting
Sponsor: GlaxoSmithKline
Neoplasms
United States, Australia, Canada, China, France +4 more
Sponsor: AstraZeneca
Idiopathic Pulmonary Fibrosis (IPF)
United States, Argentina, Australia, Bulgaria, Canada +17 more
- Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)Active Not Recruiting
Sponsor: Incyte Corporation
B-Cell Malignancies
United States, Austria, Belgium, Czechia, Denmark +12 more
Sponsor: NRG Oncology
Grade 2 Meningioma · Intracranial Meningioma
United States, Canada, India, Japan, Saudi Arabia
Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
Lipoprotein Disorder
United States, China
Sponsor: Novartis Pharmaceuticals
B-cell Acute Lymphoblastic Leukemia · Diffuse Large B-cell Lymphoma
Canada, Japan
Sponsor: GlaxoSmithKline
Solid Tumors · Neoplasms
United States, Argentina, Australia, Belgium, Brazil +10 more
Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Adenocarcinoma
China
Sponsor: Ono Pharmaceutical Co., Ltd.
Gastric Cancer
Japan, South Korea, Taiwan
- A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineTerminated
Sponsor: Eli Lilly and Company
Migraine
United States, Belgium, Canada, France, Germany +10 more
- Study of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaActive Not Recruiting
Sponsor: Kite, A Gilead Company
Relapsed/Refractory Mantle Cell Lymphoma · Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Japan
Sponsor: NovoCure GmbH
Metastatic Non-small Cell Lung Cancer
United States, Austria, Belgium, Czechia, France +11 more
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
United States, Argentina, Australia, Belgium, Brazil +32 more
Sponsor: Duk-Woo Park, MD
Coronary Artery Stenosis
United States, Australia, China, Hong Kong, India +9 more
Sponsor: Ottawa Heart Institute Research Corporation
Cardiac Sarcoidosis
Canada, Japan
Sponsor: Daiichi Sankyo Co., Ltd.
Tenosynovial Giant Cell Tumor
Japan
- Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With MigraineActive Not Recruiting
Sponsor: AbbVie
Migraine
Belgium, China, Czechia, Germany, Hungary +10 more